Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Tissue Regenix Group plc    TRX   GB00B5SGVL29

TISSUE REGENIX GROUP PLC

(TRX)
  Report
Delayed Quote. Delayed London Stock Exchange - 08/10 11:35:13 am
0.32 GBX   --.--%
02/04Tissue Regenix U.S. production resumes after cyber attack, shares jump
RE
2015TISSUE REGENIX : Preliminary Results for the Year Ended 31 January 2015
PR
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
08/04/2020 08/05/2020 08/06/2020 08/07/2020 08/10/2020 Date
0.3025(c) 0.315(c) 0.32(c) 0.32(c) 0.32(c) Last
4 833 019 38 989 516 23 249 859 18 791 466 10 703 727 Volume
0.00% +4.13% +1.59% 0.00% 0.00% Change
More quotes
Financials
Sales 2018 11,6 M 15,2 M -
Net income 2018 -8,19 M -10,7 M -
Net cash position 2018 7,82 M 10,2 M -
P/E ratio 2018 -9,30x
Yield 2018 -
Sales 2019 13,0 M 17,0 M -
Net income 2019 -6,97 M -9,09 M -
Net cash position 2019 0,09 M 0,12 M -
P/E ratio 2019 -1,68x
Yield 2019 -
Capitalization 22,5 M 29,3 M -
EV / Sales 2018 5,79x
EV / Sales 2019 0,88x
Nbr of Employees 99
Free-Float 79,2%
More Financials
Company
Tissue Regenix Group plc is a medical technology company. The Company is engaged in the development of regenerative products to make replacement native tissue using biological (human and animal) tissues. It operates through Cardiac, Wound Care and Orthopaedics divisions. Its decellularisation (dCELL) technology removes deoxyribonucleic acid and other cellular material from tissue leaving an acellular scaffold, which... 
More about the company
Latest news on TISSUE REGENIX GROUP PLC
02/04Tissue Regenix U.S. production resumes after cyber attack, shares jump
RE
2015TISSUE REGENIX : Preliminary Results for the Year Ended 31 January 2015
PR
More news
News in other languages on TISSUE REGENIX GROUP PLC
02/04Tissue Regenix U.S. production resumes after cyber attack, shares jump
2015TISSUE REGENIX : Preliminary Results for the Year Ended 31 January 2015
More news
Chart TISSUE REGENIX GROUP PLC
Duration : Period :
Tissue Regenix Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TISSUE REGENIX GROUP PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price
Last Close Price 0,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
Managers
NameTitle
Gareth Hywel Jones CEO, COO & Executive Director
Jonathan Martin Glenn Non-Executive Chairman
Kirsten Lund Secretary & Group Finance Director
Mike Izon Director-Research & Development
Alan J. Miller Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
TISSUE REGENIX GROUP PLC-68.00%29
LONZA GROUP61.66%46 473
CELLTRION, INC.73.76%35 375
IQVIA HOLDINGS INC.3.90%30 707
MODERNA, INC.278.83%29 239
SEATTLE GENETICS, INC.40.43%27 918